ZANOLA, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 564
EU - Europa 526
AS - Asia 212
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.307
Nazione #
US - Stati Uniti d'America 562
PL - Polonia 142
DE - Germania 126
CN - Cina 97
UA - Ucraina 85
IT - Italia 42
SG - Singapore 40
FI - Finlandia 33
GB - Regno Unito 32
HK - Hong Kong 30
RU - Federazione Russa 27
FR - Francia 13
IN - India 13
TR - Turchia 12
IE - Irlanda 11
CZ - Repubblica Ceca 8
VN - Vietnam 8
NL - Olanda 4
CA - Canada 2
EU - Europa 2
IR - Iran 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
ES - Italia 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
LY - Libia 1
MU - Mauritius 1
MY - Malesia 1
RO - Romania 1
SE - Svezia 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 1.307
Città #
Warsaw 142
Fairfield 63
Woodbridge 62
Jacksonville 55
Houston 53
Chandler 35
Ashburn 34
Singapore 32
Hong Kong 30
Wilmington 24
Cambridge 22
New York 22
Princeton 22
Seattle 22
Brescia 19
Ann Arbor 18
Lancaster 18
Helsinki 17
Nanjing 17
Beijing 16
Dublin 11
Changsha 9
Istanbul 9
Brno 8
Dearborn 8
Shenyang 8
Shanghai 7
Hebei 6
Jinan 6
Des Moines 5
Espoo 5
Jiaxing 5
Nanchang 5
Nürnberg 5
San Diego 5
Taizhou 5
Augusta 4
Dong Ket 4
Munich 4
Salerno 4
San Francisco 4
San Mateo 4
Los Angeles 3
Norwalk 3
Portland 3
Tianjin 3
Verona 3
Boardman 2
Cassano 2
Guangzhou 2
Gunzenhausen 2
Milan 2
Moscow 2
Ningbo 2
Taipei 2
Zhengzhou 2
Almere Stad 1
Ardabil 1
Atlanta 1
Canberra 1
Chengdu 1
Dushanbe 1
Frosinone 1
Groningen 1
Hangzhou 1
Hanoi 1
Hanover 1
Jakarta 1
Johor Bahru 1
Kocaeli 1
Leawood 1
Maastricht 1
Makawao 1
Nagoya 1
New Bedfont 1
New Delhi 1
Ottawa 1
Phoenix 1
Saigon 1
Santa Clara 1
Seoul 1
Toronto 1
Treviglio 1
Washington 1
Yerevan 1
Totale 916
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 285
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 149
Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems 138
Autofagy and apoptosis in NRK-52E renal cells exposed to cisplatin. 120
Implications for the mammalian sialidases in the physiopathology of skeletal muscle 116
Rhabdomyosarcomas: an overview on the experimental animal models. 110
ANTI-BETA2 GLYCOPROTEIN I-DOMAIN 1 AUTOANTIBODIES: COMPARISON BETWEEN TWO METHODS OF DETECTION 101
DOMAIN 1 IS THE MAIN SPECIFICITY OF ANTI-BETA2GPI ANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES 96
Domain 1 Is The Main Specificity Of Anti-b2glycoprotein I Antibodies In Systemic Autoimmune Diseases. 85
CAVEOLINS AND CAVINS IN MUSCLE-DERIVED TUMOURS 74
CAVEOLIN-1 PROMOTES PROLIFERATION AND CONFERS RESISTANCE TO OXIDATIVE STRESS-INDUCED CELL DEATH IN RHABDOMYOSARCOMA CELLS 72
Totale 1.346
Categoria #
all - tutte 4.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020112 0 0 0 0 0 0 0 28 23 34 14 13
2020/2021170 5 20 2 19 4 21 4 19 20 20 27 9
2021/202292 3 15 1 1 0 1 6 4 5 19 14 23
2022/202399 12 0 5 5 10 23 0 11 22 0 4 7
2023/2024119 11 5 16 10 0 25 7 3 23 3 5 11
2024/202597 10 0 3 35 15 15 8 11 0 0 0 0
Totale 1.346